| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.009 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.009 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.01 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |